advertisement
9.4.8 Glaucomas associated with intraocular tumors (11)
Showing records 1 to 11
Display all abstracts in classification 9.4.8 Glaucomas associated with intraocular tumors
Search within classification 9.4.8 Glaucomas associated with intraocular tumors85157 Spontaneous Hyphema from Iris Microhemangiomatosis in an Elderly Patient with Hypertensive Crisis
Nuova PJ
Case Reports in Ophthalmology 2020; 11: 68-72
84469 Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors
Kim EA
Journal of Glaucoma 2020; 29: 1-10
84095 Preservation of retinoblastoma group E eyes with neovascular glaucoma using intravenous chemotherapy: risk factors and outcomes
Rao R
British Journal of Ophthalmology 2019; 103: 1856-1861
84469 Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors
Salazar D
Journal of Glaucoma 2020; 29: 1-10
84095 Preservation of retinoblastoma group E eyes with neovascular glaucoma using intravenous chemotherapy: risk factors and outcomes
Honavar SG
British Journal of Ophthalmology 2019; 103: 1856-1861
85157 Spontaneous Hyphema from Iris Microhemangiomatosis in an Elderly Patient with Hypertensive Crisis
Zur D
Case Reports in Ophthalmology 2020; 11: 68-72
84095 Preservation of retinoblastoma group E eyes with neovascular glaucoma using intravenous chemotherapy: risk factors and outcomes
Reddy VP
British Journal of Ophthalmology 2019; 103: 1856-1861
85157 Spontaneous Hyphema from Iris Microhemangiomatosis in an Elderly Patient with Hypertensive Crisis
Loewenstein A
Case Reports in Ophthalmology 2020; 11: 68-72
84469 Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors
McCannel CA
Journal of Glaucoma 2020; 29: 1-10
85157 Spontaneous Hyphema from Iris Microhemangiomatosis in an Elderly Patient with Hypertensive Crisis
Iglicki M
Case Reports in Ophthalmology 2020; 11: 68-72
84469 Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors
Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
Journal of Glaucoma 2020; 29: 1-10
